EXAGEN INC. (XGN) › Cash & EquivalentsEXAGEN INC. (XGN) — Cash & EquivalentsAnnual figures by period end, from SEC filings.2018-12-31: $13.16M2019-12-31: $72.08M2020-12-31: $57.45M2021-12-31: $99.44M2022-12-31: $62.39M2023-12-31: $36.49M2024-12-31: $22.04M2025-12-31: $32.22M$32.22M2018-12-31Cash & Equivalents (USD)2025-12-31Period endedCash & EquivalentsChange YoYSource filing2025-12-31$32.22M+46.2%2026-03-10Balance as of period end2024-12-31$22.04M-39.6%2026-03-10Balance as of period end2023-12-31$36.49M-41.5%2025-03-11Balance as of period end2022-12-31$62.39M-37.3%2024-03-18Balance as of period end2021-12-31$99.44M+73.1%2023-03-20Balance as of period end2020-12-31$57.45M-20.3%2022-03-22Balance as of period end2019-12-31$72.08M+447.6%2021-03-16Balance as of period end2018-12-31$13.16M—2020-03-25Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)